GLP-1s Like Ozempic, Wegovy Don’t Substantially Increase Thyroid Cancer Risk, Study Suggests
Participants taking popular diabetes and weight loss drugs called GLP-1s were compared to those taking two other types of diabetes drugs, and the researchers found no substantial increase in thyroid cancer risk in the GLP-1 patients.
Participants taking popular diabetes and weight loss drugs called GLP-1s were compared to those taking two other types of diabetes drugs, and the researchers found no substantial increase in thyroid cancer risk in the GLP-1 patients.
What's Your Reaction?
